CytomX Therapeutics, Inc. - COM (CTMX)

Historical Portfolio Holders from Q4 2015 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	43.4 M	$94.7 M	+$23.8 M	9.81 K	229 K	$2.18	82
2023 Q4	31.4 M	$48.7 M	+$392 K	4.96 K	30.2 K	$1.55	62
2023 Q3	31.3 M	$40.3 M	-$2.41 M	4.39 K	44.5 K	$1.29	59
2023 Q2	34.1 M	$58.7 M	-$2.38 M	18.2 K	60.4 K	$1.72	64
2023 Q1	34.5 M	$52 M	-$652 K	53.8 K	22 K	$1.51	71
2022 Q4	34.6 M	$55.4 M	-$51.5 K	54.1 K	28.5 K	$1.60	74
2022 Q3	36.3 M	$52.6 M	-$18.7 M		22 K	$1.45	73
2022 Q2	45.2 M	$82.7 M	-$18.5 M	0	27 K	$1.83	84
2022 Q1	53.7 M	$143 M	-$1.36 M	30 K	44 K	$2.67	108
2021 Q4	54.2 M	$235 M	-$5.21 M	279 K	202 K	$4.33	102
2021 Q3	53.8 M	$274 M	-$13 M	213 K	0	$5.09	109
2021 Q2	55.8 M	$353 M	-$141 K	292 K	120 K	$6.33	113
2021 Q1	54.6 M	$422 M	+$131 M	739 K	264 K	$7.73	122
2020 Q4	37.9 M	$248 M	+$6.77 M		88 K	$6.55	120
2020 Q3	36.8 M	$245 M	-$11.5 M		70 K	$6.65	124
2020 Q2	37.7 M	$314 M	+$28.2 M			$8.33	128
2020 Q1	35.3 M	$270 M	+$523 K			$7.67	106
2019 Q4	35.7 M	$297 M	-$9.66 M		0	$8.31	114
2019 Q3	35.8 M	$264 M	+$884 K		80 K	$7.38	108
2019 Q2	35.6 M	$400 M	-$8.08 M			$11.22	106
2019 Q1	36.6 M	$394 M	-$12.8 M		0	$10.75	103
2018 Q4	37.5 M	$567 M	+$45.7 K	0	168 K	$15.10	103
2018 Q3	37.7 M	$697 M	+$95.6 M	459 K	718 K	$18.50	117
2018 Q2	32.1 M	$734 M	+$67 M	261 K	2.72 M	$22.86	136
2018 Q1	28.6 M	$813 M	+$71.8 M		2.56 M	$28.45	134
2017 Q4	30 M	$634 M	+$55.5 M			$21.11	117
2017 Q3	24.2 M	$441 M	+$43 M			$18.17	97
2017 Q2	22.1 M	$343 M	+$44.9 M			$15.50	87
2017 Q1	19.2 M	$331 M	+$57.7 M			$17.27	85
2016 Q4	16.9 M	$185 M	+$15 M			$10.99	68
2016 Q3	15.5 M	$243 M	+$18.1 M			$15.68	60
2016 Q2	14.6 M	$149 M	+$16 M			$10.21	56
2016 Q1	12.8 M	$164 M	+$3.31 M			$12.90	45
2015 Q4	12.5 M	$258 M	+$240 M			$20.87	46